This review summarizes important publications that have appeared during the last year
dealing with imaging techniques and endoscopy, as well as the management of low-grade
dysplasia and stenosis in inflammatory bowel disease. Magnetic resonance enteroclysis
and capsule endoscopy are currently emerging as new imaging techniques for the small
bowel in Crohn’s disease. While magnetic resonance enteroclysis is, at least in Europe,
increasingly being used as a reference method, the value of capsule endoscopy for
the management of inflammatory bowel disease is still being evaluated. Chromoendoscopy
is being studied in patients with long-lasting ulcerative colitis and may be a promising
and sensitive technique for the diagnosis of dysplasia. However, there are conflicting
data regarding the appropriate management when low-grade dysplasia is diagnosed in
patients with ulcerative colitis. Endoscopic dilation can often be successfully carried
out in cases of intestinal stenosis. The results of long-term follow-up studies indicate
that several dilation procedures are often necessary and that a relatively high percentage
of patients still have to undergo surgery.
References
- 1
Parente F, Greco S, Molteni M. et al .
Role of early ultrasound in detecting inflammatory intestinal disorders and identifying
their anatomical location within the bowel.
Aliment Pharmacol Ther.
2003;
18
1009-1016
- 2
Rapaccini G L, Pompili M, Orefice R. et al .
Contrast-enhanced power Doppler of the intestinal wall in the evaluation of patients
with Crohn disease.
Scand J Gastroenterol.
2004;
39
188-194
- 3
Schreyer A G, Geissler A, Albrich H. et al .
Abdominal MRI after enteroclysis or with oral contrast in patients with suspected
or proven Crohn’s disease.
Clin Gastroenterol Hepatol.
2004;
2
491-497
- 4
Wold P B, Fletcher J G, Johnson C D. et al .
Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared
with other imaging methods and endoscopy: feasibility study.
Radiology.
2003;
229
275-281
- 5
Gourtsoyiannis N, Papanikolaou N, Grammatikakis J. et al .
Assessment of Crohn’s disease activity in the small bowel with MR and conventional
enteroclysis: preliminary results.
Eur Radiol.
2004;
14
1017-1024
- 6
Madsen S M, Thomsen H S, Schlichting P. et al .
Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance
imaging.
Abdom Imaging.
1999;
24
232-239
- 7
Narin B, Ajaj W, Gohde S. et al .
Combined small and large bowel MR imaging in patients with Crohn’s disease: a feasibility
study.
Eur Radiol.
2004;
14
1535-1542
- 8
Debatin J F, Lauenstein T C.
Virtual magnetic resonance colonography.
Gut.
2003;
52 (Suppl)
17-22
- 9
Schreyer A G, Golder S, Seitz J. et al .
New diagnostic avenues in inflammatory bowel diseases: capsule endoscopy, magnetic
resonance imaging and virtual enteroscopy.
Dig Dis.
2003;
21
129-137
- 10
Fireman Z, Mahajna E, Broide E. et al .
Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy.
Gut.
2003;
52
390-392
- 11
Eliakim R, Fischer D, Suissa A. et al .
Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium
follow-through and computerized tomography in patients with suspected Crohn’s disease.
Eur J Gastroenterol Hepatol.
2003;
15
363-367
- 12
Voderholzer W A, Ortner M, Rogalla P. et al .
Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography
enteroclysis.
Endoscopy.
2003;
35
1009-1014
- 13
Mow W S, Lo S K, Targan S R. et al .
Initial experience with wireless capsule enteroscopy in the diagnosis and management
of inflammatory bowel disease: diagnostic yield of wireless capsule enteroscopy in
comparison with computed tomography enteroclysis.
Clin Gastroenterol Hepatol.
2004;
2
31-40
- 14
Lo S K.
Capsule endoscopy in the diagnosis and management of inflammatory bowel disease.
Gastrointest Endosc Clin N Am.
2004;
14
179-193
- 15
Modigliani R.
Endoscopic severity index for Crohn’s disease [letter].
Gastrointest Endosc.
1990;
36
637
- 16
Modigliani R, Mary J Y, Simon J F. et al .
Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution
on prednisolone. Groupe d’Etude Thérapeutique des Affections Inflammatoires Digestives.
Gastroenterology.
1990;
98
811-818
- 17
McLeod R S, Wolff B G, Steinhart A H. et al .
Risk and significance of endoscopic/radiological evidence of recurrent Crohn’s disease.
Gastroenterology.
1997;
113
1823-1827
- 18
Rutgeerts P.
Modern therapy for inflammatory bowel disease.
Scand J Gastroenterol Suppl.
2003;
237
30-33
- 19
Kiesslich R, Fritsch J, Holtmann M. et al .
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia
and colon cancer in ulcerative colitis.
Gastroenterology.
2003;
124
880-888
- 20
Rutter M D, Saunders B P, Schofield G. et al .
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative
colitis.
Gut.
2004;
53
256-260
- 21
Ajaj W, Pelster G, Treichel U. et al .
Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy
for the detection of colorectal pathology.
Gut.
2003;
52
1738-1743
- 22
Schreyer A G, Rath H C, Kikinis R. et al .
A comparison of MRI colonography with conventional colonoscopy for the assessment
of intestinal inflammation in patients with inflammatory bowel disease: a feasibility
study.
Gut.
2004;
in press
- 23
Itzkowitz S H, Harpaz N.
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
Gastroenterology.
2004;
126
1634-1648
- 24
Munkholm P.
Review article: the incidence and prevalence of colorectal cancer in inflammatory
bowel disease.
Aliment Pharmacol Ther.
2003;
18
1-5
- 25
Rutter M, Saunders B, Wilkinson K. et al .
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Gastroenterology.
2004;
126
451-459
- 26
Bernstein C, Shanahan F, Weinstein W M.
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?.
Lancet.
1994;
343
71-74
- 27
Ullman T, Croog V, Harpaz N. et al .
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative
colitis.
Gastroenterology.
2003;
125
1311-1319
- 28
Lim C H, Dixon M F, Vail A. et al .
Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.
Gut.
2003;
52
1127-1132
- 29
Lynch D A, Lobo A J, Sobala G M. et al .
Failure of colonoscopic surveillance in ulcerative colitis.
Gut.
1993;
34
1075-1080
- 30
Connell W R, Lennard-Jones J E, Williams C B. et al .
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative
colitis.
Gastroenterology.
1994;
107
934-944
- 31
Eaden J, Abrams K, McKay H. et al .
Inter-observer variation between general and specialist gastrointestinal pathologists
when grading dysplasia in ulcerative colitis.
J Pathol.
2001;
194
152-157
- 32
Eaden J A, Ward B A, Mayberry J F.
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis
of performance.
Gastrointest Endosc.
2000;
51
123-128
- 33
Hanauer S B.
Surveying surveillance: are gastroenterologists consistently inconsistent, inconsistently
consistent, or poorly educated?.
Gastrointest Endosc.
2000;
51
240-242
- 34
Befrits R, Ljung T, Jaramillo E. et al .
Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up
study.
Dis Colon Rectum.
2002;
45
615-620
- 35
Bernstein C N, Weinstein W M, Levine D S. et al .
Physicians’ perceptions of dysplasia and approaches to surveillance colonoscopy in
ulcerative colitis.
Am J Gastroenterol.
1995;
90
2106-2114
- 36
Ullman T A, Loftus E V , Kakar S. et al .
The fate of low grade dysplasia in ulcerative colitis.
Am J Gastroenterol.
2002;
97
922-927
- 37
Sabate J M, Villarejo J, Bouhnik Y. et al .
Hydrostatic balloon dilatation of Crohn’s strictures.
Aliment Pharmacol Ther.
2003;
18
409-413
- 38
Morini S, Hassan C, Lorenzetti R. et al .
Long-term outcome of endoscopic pneumatic dilatation in Crohn’s disease.
Dig Liver Dis.
2003;
35
893-897
- 39
Thomas-Gibson S, Brooker J C, Hayward C M. et al .
Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes.
Eur J Gastroenterol Hepatol.
2003;
15
485-488
- 40
Loftus E V .
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental
influences.
Gastroenterology.
2004;
126
1504-1517
- 41
Brooker J C, Beckett C G, Saunders B P. et al .
Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures
may improve the outcome: a retrospective case series.
Endoscopy.
2003;
35
333-337
- 42
Holzknecht N, Helmberger T, von Ritter C. et al .
MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis
with oral iron particles.
Radiologe.
1998;
38
29-36
- 43
Schunk K, Kern A, Heussel C P. et al .
Hydro-MRT with fast sequences in Crohn’s disease: a comparison with fractionated gastrointestinal
passage.
Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr.
1999;
170
338-346
- 44
Aschoff A J, Zeitler H, Merkle E M. et al .
MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases
with contrast enhancement.
Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr.
1997;
167
387-391
- 45
Rieber A, Wruk D, Nussle K. et al .
MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous
Gd-DTPA.
Radiologe.
1998;
38
23-28
H. Herfarth, M. D.
Klinik und Poliklinik für Innere Medizin I
Universität Regensburg · 93042 Regensburg · Germany
Fax: +49-941-944-7179
Email: Hans.Herfarth@klinik.uni-regensburg.de